Penumbra, Inc. (NYSE:PEN) Shares Sold by Mutual of America Capital Management LLC

Mutual of America Capital Management LLC cut its holdings in Penumbra, Inc. (NYSE:PEN) by 3.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 21,095 shares of the company’s stock after selling 797 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Penumbra were worth $5,010,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also made changes to their positions in PEN. True Wealth Design LLC purchased a new position in shares of Penumbra during the third quarter worth about $26,000. UMB Bank n.a. lifted its position in Penumbra by 57.4% during the 4th quarter. UMB Bank n.a. now owns 192 shares of the company’s stock worth $46,000 after acquiring an additional 70 shares during the period. Mather Group LLC. grew its stake in shares of Penumbra by 208.0% in the 4th quarter. Mather Group LLC. now owns 308 shares of the company’s stock valued at $73,000 after purchasing an additional 208 shares during the last quarter. Advisors Asset Management Inc. increased its holdings in shares of Penumbra by 11.5% in the third quarter. Advisors Asset Management Inc. now owns 416 shares of the company’s stock valued at $81,000 after purchasing an additional 43 shares during the period. Finally, GAMMA Investing LLC raised its stake in shares of Penumbra by 160.8% during the fourth quarter. GAMMA Investing LLC now owns 446 shares of the company’s stock worth $106,000 after purchasing an additional 275 shares during the last quarter. 88.88% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, Director Harpreet Grewal sold 167 shares of the company’s stock in a transaction that occurred on Friday, January 3rd. The stock was sold at an average price of $241.28, for a total value of $40,293.76. Following the sale, the director now owns 8,530 shares of the company’s stock, valued at approximately $2,058,118.40. This represents a 1.92 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Adam Elsesser sold 15,000 shares of the stock in a transaction on Friday, December 20th. The shares were sold at an average price of $242.96, for a total value of $3,644,400.00. Following the sale, the chief executive officer now owns 837,582 shares in the company, valued at approximately $203,498,922.72. This trade represents a 1.76 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 5.00% of the company’s stock.

Analyst Ratings Changes

A number of research firms recently weighed in on PEN. Oppenheimer assumed coverage on shares of Penumbra in a research report on Tuesday, December 17th. They issued an “outperform” rating and a $275.00 price objective on the stock. Truist Financial lifted their target price on shares of Penumbra from $285.00 to $325.00 and gave the company a “buy” rating in a report on Wednesday, February 19th. JPMorgan Chase & Co. boosted their price target on shares of Penumbra from $230.00 to $285.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 19th. Wells Fargo & Company raised their price objective on shares of Penumbra from $275.00 to $305.00 and gave the company an “overweight” rating in a research report on Wednesday, February 19th. Finally, BTIG Research boosted their target price on Penumbra from $232.00 to $270.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. Four analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, Penumbra currently has an average rating of “Moderate Buy” and a consensus target price of $292.64.

Penumbra Stock Down 0.7 %

PEN opened at $283.97 on Wednesday. Penumbra, Inc. has a one year low of $148.00 and a one year high of $310.00. The company has a market cap of $10.94 billion, a price-to-earnings ratio of 835.19, a PEG ratio of 2.83 and a beta of 0.53. The business’s fifty day moving average is $265.03 and its two-hundred day moving average is $233.89. The company has a debt-to-equity ratio of 0.02, a quick ratio of 3.25 and a current ratio of 6.01.

Penumbra (NYSE:PEN) last released its quarterly earnings data on Tuesday, February 18th. The company reported $0.97 EPS for the quarter, topping the consensus estimate of $0.88 by $0.09. Penumbra had a net margin of 1.17% and a return on equity of 9.74%. The business had revenue of $315.52 million for the quarter, compared to analyst estimates of $311.63 million. Analysts anticipate that Penumbra, Inc. will post 3.67 EPS for the current fiscal year.

About Penumbra

Penumbra, Inc, together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.